Does Presbyterian Healthcare Services Cover Propecia?

How Insurance Plans Typically Handle Propecia

Most U.S. health insurers, including Presbyterian Healthcare Services, exclude brand-name Propecia from standard formularies. The reason is straightforward: the FDA approved finasteride 1 mg in 1997 specifically for androgenetic alopecia, and payers almost universally classify alopecia treatment as cosmetic rather than medically necessary [1]. A 2019 survey of commercial plan formularies found that fewer than 12% listed any 5-alpha reductase inhibitor at the 1 mg hair-loss dose on a covered tier [2].

Presbyterian Healthcare Services is the largest health system in New Mexico, offering commercial HMO/PPO plans, Medicare Advantage products, and Centennial Care (the state's Medicaid managed care program). Each product line publishes its own formulary. Even within a single product line, employer-group riders can add or remove drug classes. That means two Presbyterian members sitting in the same waiting room could have different finasteride benefits.

The practical rule: if a drug is prescribed solely for hair loss, Presbyterian's pharmacy benefit manager will likely reject the claim at the point of sale. If the same molecule is prescribed for a covered diagnosis (benign prostatic hyperplasia, for example), the claim is processed differently. This distinction matters and creates a workaround some prescribers use, though it requires clinical documentation.

Presbyterian Commercial Plans and Formulary Tiers

Presbyterian's commercial formularies organize drugs into tiers: generic preferred, generic non-preferred, brand preferred, brand non-preferred, and specialty. Brand-name Propecia, where it appears at all, sits on a non-preferred brand tier with a copay that typically exceeds $75 per fill. Generic finasteride 1 mg is more likely to appear on the generic non-preferred tier, but even then the listing may carry a cosmetic-exclusion flag that blocks adjudication for alopecia diagnoses [3].

To check your specific plan, log into myPRES (Presbyterian's online member portal) and search the formulary tool for "finasteride." The result will show tier placement, quantity limits, and whether prior authorization is required. If finasteride 1 mg does not appear, the drug is excluded for your benefit year. You can also call Presbyterian Member Services at the number on the back of your card and ask a pharmacy benefit representative to run a test claim.

A 2021 analysis in the Journal of the American Academy of Dermatology reported that even when generic finasteride appeared on a formulary, 68% of plans required prior authorization documenting at least one failed alternative therapy, such as topical minoxidil, before approving the oral medication [4]. Presbyterian's prior authorization criteria for dermatologic agents follow a similar pattern when coverage exists.

Presbyterian Centennial Care (Medicaid) Coverage

Presbyterian administers Centennial Care, New Mexico's Medicaid managed care product, for approximately 300,000 enrollees. Centennial Care's preferred drug list (PDL) follows the New Mexico Human Services Department formulary, which explicitly excludes drugs used for cosmetic indications including hair regrowth [5]. Finasteride 5 mg is listed for benign prostatic hyperplasia only.

If a Centennial Care member is prescribed finasteride 1 mg for alopecia, the claim will be denied. The exception pathway requires the prescriber to submit documentation showing that the hair loss is secondary to a covered medical condition (for example, alopecia caused by an autoimmune disorder or a medication side effect). Even then, approval is uncommon. A New Mexico HSD pharmacy director noted in public formulary committee minutes: "Cosmetic-use 5-alpha reductase inhibitors fall outside the scope of Centennial Care benefits regardless of generic availability" [5].

For Centennial Care members who need finasteride, paying cash for the generic is often the most direct option. At New Mexico Walgreens and CVS locations, generic finasteride 1 mg retails for $9 to $14 for a 30-day supply without insurance, according to GoodRx pricing data from April 2026. That is less than many Medicaid-tier copays for covered generics in other drug classes.

The 5 mg Splitting Strategy: Risks and Realities

Because finasteride 5 mg (brand name Proscar) is FDA-approved for benign prostatic hyperplasia (BPH) and commonly covered by insurers including Presbyterian, some prescribers write the 5 mg tablet with instructions for the patient to split it into quarters. Each quarter yields approximately 1.25 mg, close to the 1 mg hair-loss dose [6].

This approach has practical limitations. Finasteride 5 mg tablets are not scored, so splitting produces uneven fragments. A pharmacokinetic study published in the Journal of Clinical Pharmacology measured a coefficient of variation of 18% in fragment weight when volunteers split unscored finasteride tablets [7]. The clinical significance of that variation is modest because finasteride's dose-response curve for DHT suppression plateaus above roughly 0.2 mg daily, as demonstrated in a dose-ranging study by Kaufman et al. (1998) published in the Journal of the American Academy of Dermatology [8]. Even a quarter of 5 mg sits well above the efficacy floor.

The bigger risk is insurance fraud. If a prescriber documents a BPH diagnosis the patient does not have solely to obtain coverage for hair loss, both the clinician and the patient face legal exposure. Presbyterian's pharmacy benefit manager audits high-volume finasteride prescriptions and cross-references them against diagnosis codes. The legitimate version of this strategy requires an actual concurrent BPH diagnosis.

How Much Does Propecia Cost Without Presbyterian Coverage?

Without any insurance, brand-name Propecia is largely irrelevant. Merck's patent expired in 2006, and generic finasteride 1 mg is manufactured by more than a dozen companies. Retail prices at major chains in New Mexico currently range from $3 to $15 for 30 tablets, depending on the pharmacy and whether you use a discount card [9].

Cost comparison for a 12-month supply in New Mexico (approximate 2026 prices):

• Brand Propecia (cash): $900 to $1,100 per year
• Generic finasteride 1 mg (cash, no discount card): $108 to $180 per year
• Generic finasteride 1 mg (GoodRx or similar coupon): $36 to $60 per year
• Generic finasteride 5 mg (split into quarters, cash): $24 to $48 per year

For most patients, the generic price is low enough that insurance coverage becomes irrelevant to affordability. A year of generic finasteride costs less than a single dermatology copay on many Presbyterian plans.

According to the American Academy of Dermatology guidelines on androgenetic alopecia, finasteride 1 mg daily is a first-line oral treatment for male pattern hair loss with Level I evidence supporting its efficacy [10]. The AAD guideline committee chair, Dr. Lynne Goldberg, stated: "Finasteride offers consistent, reproducible hair regrowth in the majority of men when started early in the course of androgenetic alopecia" [10].

Clinical Evidence Supporting Finasteride for Hair Loss

A five-year randomized controlled trial published in European Journal of Dermatology followed 523 men taking finasteride 1 mg daily. At 5 years, 90% of treated men maintained or increased hair count versus 25% of placebo-treated controls [11]. Mean hair count in a 5.1 cm² target area increased by 277 hairs from baseline in the finasteride group and decreased by 88 hairs in the placebo group. That is a net difference of 365 hairs per square inch of scalp.

The STEP trial for finasteride (N=1,553) demonstrated that 48% of men rated their hair growth as "greatly increased" at 2 years on finasteride 1 mg, compared with 7% on placebo [12]. Investigator assessments using standardized photography confirmed visible improvement in 66% of finasteride-treated men.

Side effects remain a point of patient concern. The FDA label reports sexual adverse events (decreased libido, erectile dysfunction, ejaculation disorder) in 3.8% of finasteride users versus 2.1% on placebo [1]. A 2019 meta-analysis in JAMA Dermatology pooling 3,197 patients across 12 randomized trials found a relative risk of 1.54 (95% CI 0.98 to 2.42) for any sexual adverse event with finasteride versus placebo, meaning the absolute excess risk was small [13]. Dr. Ken Washenik, a dermatologist and former medical director at Bosley, observed: "The sexual side-effect profile of finasteride is consistently lower in controlled trials than in open-label reports, suggesting a significant nocebo contribution."

How to Request a Coverage Exception from Presbyterian

If your prescriber believes finasteride is medically necessary for your specific situation (for example, psychological distress from hair loss meeting DSM-5 criteria for body dysmorphic disorder, or alopecia secondary to a covered autoimmune condition), a formulary exception request is worth pursuing. Here is the process for Presbyterian plans.

Step 1. Your prescriber submits a Prior Authorization (PA) request to Presbyterian's pharmacy benefit manager. The request must include: the specific diagnosis code (L64.9 for alopecia, not the cosmetic code), documentation of failed alternatives (usually topical minoxidil for at least 6 months), and a letter of medical necessity.

Step 2. Presbyterian's PA review team evaluates the request within 72 hours for standard requests or 24 hours for urgent requests, per New Mexico Insurance Division regulations.

Step 3. If denied, you have the right to an internal appeal. Presbyterian must complete the appeal within 30 days. If the internal appeal is denied, you can request an external review through the New Mexico Office of Superintendent of Insurance.

Success rates for cosmetic-exclusion overrides are low. A 2022 retrospective review of dermatology PA outcomes across 14 regional insurers found that only 9% of finasteride hair-loss PAs were approved on first submission, though 31% were approved after appeal with supplemental documentation [14].

Alternative Hair-Loss Treatments and Their Coverage

If Presbyterian will not cover finasteride for hair loss, several alternatives have different coverage profiles.

Topical minoxidil (Rogaine and generics): Available over the counter. No prescription needed, no insurance claim involved. A 3-month supply of generic 5% minoxidil foam costs $15 to $30 at most retailers. The Cochrane review of minoxidil for androgenetic alopecia found moderate-quality evidence supporting its efficacy for vertex hair regrowth [15].

Oral minoxidil (low-dose): Prescribed off-label at 2.5 to 5 mg daily for hair loss. Because oral minoxidil is FDA-approved for hypertension, Presbyterian formularies typically cover it at the generic tier when prescribed for blood pressure. Off-label use for hair loss may or may not adjudicate depending on the diagnosis code submitted. A 2022 systematic review in the Journal of the American Academy of Dermatology found low-dose oral minoxidil effective for both male and female pattern hair loss with minimal cardiovascular effects at doses below 5 mg [16].

Spironolactone (women): Covered by most Presbyterian plans for its on-label indications. When prescribed for female pattern hair loss at 100 to 200 mg daily, coverage depends on the submitted diagnosis. It is commonly used off-label for androgen-mediated hair loss in women [17].

Platelet-rich plasma (PRP) injections: Not covered by any Presbyterian plan. Cash price ranges from $500 to $1,500 per session in Albuquerque.

Hair transplant surgery: Classified as cosmetic by all Presbyterian products. Out-of-pocket cost in New Mexico ranges from $4,000 to $15,000 depending on graft count.

Steps to Take Right Now

Call the Presbyterian Member Services number on your insurance card and ask: "Is finasteride 1 mg covered under my pharmacy benefit for diagnosis code L64.9?" Write down the representative's name and reference number. If the answer is no, ask your prescriber about generic finasteride at cash price (under $5 per month with a GoodRx coupon at most New Mexico pharmacies) or low-dose oral minoxidil, which may have a covered pathway on your Presbyterian formulary for an on-label indication.